Bristol-Myers Squibb seems to be running into problems left and right. With drug recalls, pending lawsuits and ill-perceived clinical trials, Bristol-Myers is facing numerous struggles in the pharmaceutical industry.
Bristol-Myers and Sanofi Aventis (another pharmaceutical company) are being co-accused in a lawsuit regarding Plavix, news outlets report. Plavix, a drug designed to prevent heart attacks and strokes in patients who are at risk, has been claimed by one woman to have caused her severe intestinal bleeding. According to Mel Daris, a Seeking Alpha contributor, the allegations state that Bristol-Myers and Sanofi “were aware that the safety information was inaccurate and misleading.”
Bristol-Myers sponsored clinical trials to study the efficacy of INX-189 – renamed by Bristol-Myers to BMS-986094 – a potential breakthrough Hepatitis C drug. The trial was halted and the development of the drug stopped after reports of severe side effects.
The details of the Hepatitis C clinical trial and its aftermath:
Thomas J. Henry are leaders in the area of product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively. We represent a multitude of people who are battling against manufacturers of defective drugs and/or products.
Your choice does matter. If you or a loved one has suffered serious injuries because of a recalled product, call Thomas J. Henry immediately. We are available 24/7, nights and weekends.